The White House Watch newsletter is now available for free, offering readers a comprehensive guide to what President Trump’s second term means for Washington, business, and the world. The newsletter provides valuable insights and analysis on the latest developments in global trade, politics, and economics.
In recent news, President Trump has announced plans to impose significant tariffs on copper and pharmaceuticals as part of his administration’s efforts to escalate the global trade war. The President stated that the US will be imposing a 50% tariff on copper, with potential levies of up to 200% on drug imports after an 18-month transition period.
These new tariffs come on the heels of letters sent by President Trump to 14 trading partners, including Japan and South Korea, informing them of steep levies set to take effect on August 1. Trump has made it clear that there will be no extensions beyond this deadline for striking trade deals, emphasizing his administration’s commitment to reshaping international trade relations.
Commerce Secretary Howard Lutnick has indicated that the copper tariffs could be implemented by the end of this month or early August, leading to a surge in US copper prices and boosting shares of companies like Freeport-McMoRan. The move has raised concerns within the industry, particularly in Canada, a major supplier of refined copper to the US.
On the pharmaceutical front, President Trump has hinted at imposing tariffs on imported drugs, giving companies a year to adjust before facing high rates of up to 200%. The announcement has caused fluctuations in the S&P 500 pharmaceuticals index, signaling potential impacts on the industry in the future.
Despite the looming threat of tariffs, Washington lobbyists believe that pharmaceutical companies may not face significant risks in the near term. The US has already implemented tariffs on autos and steel, with ongoing investigations into other sectors such as copper, lumber, and aerospace, further fueling uncertainty among trading partners.
The Section 232 investigations conducted by the US have created challenges for countries seeking exemptions from tariffs, with the UK being the only country to secure a reduced tariff on cars as part of a recent deal. Negotiations are ongoing between the US and the UK for additional carve-outs on steel imports and pharmaceutical tariffs.
As the trade war intensifies, the White House Watch newsletter will continue to provide in-depth analysis and updates on the shifting landscape of international trade relations. Stay informed and sign up for free access to exclusive content on the implications of President Trump’s policies on the global economy.
